A phase 1 randomized, 3 period, 6‐sequence crossover study in healthy male and postmenopausal female subjects evaluating the effect of a formulation change and food on belvarafenib exposure
Latest Information Update: 23 Apr 2021
At a glance
- Drugs Belvarafenib (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 23 Apr 2021 New trial record
- 17 Mar 2021 Results presented at the 122nd Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics